Status:
COMPLETED
Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)
Lead Sponsor:
Carelon Research
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Thalassemia Clinical Research Network
Conditions:
Anemia, Cooley's
Beta-Thalassemia
Eligibility:
All Genders
1-75 years
Brief Summary
The purpose of the TCRN is to accelerate research in the management of thalassemia, standardize existing treatments, and evaluate new ones in a network of clinical centers in North America. The emphas...
Detailed Description
BACKGROUND: Cooley's anemia (beta-thalassemia major, hereafter referred to as thalassemia) is a severe, inherited blood disorder characterized by a quantitative defect in the synthesis of the beta ch...
Eligibility Criteria
Please refer to specific studies for eligibility criteria.
Key Trial Info
Start Date :
July 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2006
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00000623
Start Date
July 1 2000
End Date
July 1 2006
Last Update
March 4 2014
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Oakland
Oakland, California, United States, 94609
2
Children's Hospital
Boston, Massachusetts, United States, 02115
3
Weill Medical College of Cornell University
New York, New York, United States, 10021
4
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104